Alpha Tau Medical Ltd. (DRTS)
USD 3.18
(1.92%)
USD 3.18
(1.92%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | - | - | - | - | - |
| Cost of Revenue | 1.07 Million | 979 Thousand | 776 Thousand | 86 Thousand | - |
| Gross Profit | -1.07 Million | -979 Thousand | -776 Thousand | -86 Thousand | - |
| Operating Expenses | -35.68 Million | 32.13 Million | 13.79 Million | 9.24 Million | 8.01 Million |
| Selling, General and Administrative Expenses | 9.25 Million | 11.24 Million | 2.34 Million | 1.7 Million | 1.37 Million |
| Research and Development Expenses | 27.26 Million | 20.89 Million | 11.44 Million | 7.54 Million | 6.63 Million |
| Other Expenses | -72.2 Million | - | - | - | - |
| Cost and Expenses | -35.68 Million | 32.13 Million | 13.79 Million | 9.24 Million | 8.01 Million |
| Operating Income | 35.68 Million | -32.13 Million | -13.79 Million | -9.24 Million | -8.01 Million |
| Interest Expense | 39 Thousand | 1.76 Million | 13.27 Million | 217 Thousand | - |
| Income Tax Expense | 16 Thousand | 20 Thousand | 7000.00 | 158 Thousand | 146 Thousand |
| Earnings before Tax | -29.14 Million | -33.74 Million | -27.26 Million | -8.72 Million | -8.31 Million |
| Net Income | -29.15 Million | -33.76 Million | -27.27 Million | -8.88 Million | -8.46 Million |
| Earnings Per Share Basic | -0.42 | -0.53 | -0.67 | -0.22 | -0.13 |
| Earnings Per Share Diluted | -0.42 | -0.53 | -0.67 | -0.22 | -0.13 |
| Weighted Average Shares Outstanding | 69.37 Million | 63.53 Million | 40.52 Million | 40.43 Million | 67.62 Million |
| Weighted Average Shares Outstanding (Diluted) | 69.37 Million | 63.53 Million | 40.52 Million | 40.43 Million | 67.62 Million |
| Gross Margin | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - |
| Profit Margin | - | - | - | - | - |
| EBITDA | -34.6 Million | -32.74 Million | -13.21 Million | -9.15 Million | -7.94 Million |
| Earnings Before Tax Margin | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | 1.07 Million | 1.07 Million | - | 512 Thousand |
| Gross Profit | - | - | -1.07 Million | -1.07 Million | - | -512 Thousand |
| Operating Expenses | 9.05 Million | 8.42 Million | 8.86 Million | 34.6 Million | 8.92 Million | 8.16 Million |
| Selling, General and Administrative Expenses | 2.18 Million | 1.97 Million | 1.37 Million | - | 2.25 Million | 2.21 Million |
| Research and Development Expenses | 6.86 Million | 6.44 Million | 7.49 Million | - | 6.67 Million | 5.95 Million |
| Other Expenses | - | 6.44 Million | - | - | - | - |
| Cost and Expenses | 9.05 Million | 8.42 Million | 9.94 Million | 35.68 Million | 8.92 Million | 8.16 Million |
| Operating Income | -9.05 Million | -8.42 Million | -9.94 Million | -35.68 Million | -8.92 Million | -8.16 Million |
| Interest Expense | - | - | - | 39 Thousand | - | - |
| Income Tax Expense | 3000.00 | 1000.00 | 8000.00 | 16 Thousand | -39 Thousand | 26 Thousand |
| Earnings before Tax | -7.36 Million | -7.98 Million | -7.35 Million | -29.14 Million | -4.95 Million | -8.66 Million |
| Net Income | -7.36 Million | -7.98 Million | -7.36 Million | -29.15 Million | -4.91 Million | -8.69 Million |
| Earnings Per Share Basic | -0.11 | -0.11 | -0.11 | - | -0.07 | -0.13 |
| Earnings Per Share Diluted | -0.11 | -0.11 | -0.11 | - | -0.07 | -0.13 |
| Weighted Average Shares Outstanding | 69.87 Million | 69.71 Million | 69.67 Million | 69.37 Million | 69.47 Million | 69.31 Million |
| Weighted Average Shares Outstanding (Diluted) | 69.87 Million | 69.71 Million | 69.67 Million | 69.37 Million | 69.47 Million | 69.31 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -9.05 Million | -8.42 Million | -8.86 Million | - | -8.92 Million | -8.16 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
VAHN
HINKF
0LTG
FFTTF
000048
CMRZF